Johnson & Johnson beats on earnings and revenue, raises full-year guidance

J&J, whose financial results are considered a bellwether for many health companies, said its first-quarter sales grew 5.6% over the same quarter last year. 

from Health and Science https://ift.tt/nbd5aSo
https://ift.tt/sR7S9B8
https://ift.tt/dyTDxb1